JP2010518122A5 - - Google Patents

Download PDF

Info

Publication number
JP2010518122A5
JP2010518122A5 JP2009549268A JP2009549268A JP2010518122A5 JP 2010518122 A5 JP2010518122 A5 JP 2010518122A5 JP 2009549268 A JP2009549268 A JP 2009549268A JP 2009549268 A JP2009549268 A JP 2009549268A JP 2010518122 A5 JP2010518122 A5 JP 2010518122A5
Authority
JP
Japan
Prior art keywords
composition
treprostinil
pulmonary fibrosis
kit
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009549268A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010518122A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/053467 external-priority patent/WO2008098196A1/en
Publication of JP2010518122A publication Critical patent/JP2010518122A/ja
Publication of JP2010518122A5 publication Critical patent/JP2010518122A5/ja
Withdrawn legal-status Critical Current

Links

JP2009549268A 2007-02-09 2008-02-08 間質性肺疾患および喘息のためのトレプロスチニル処置 Withdrawn JP2010518122A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90032007P 2007-02-09 2007-02-09
US94021807P 2007-05-25 2007-05-25
PCT/US2008/053467 WO2008098196A1 (en) 2007-02-09 2008-02-08 Treprostinil treatment for interstitial lung disease and asthma

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013116923A Division JP2013189459A (ja) 2007-02-09 2013-06-03 間質性肺疾患および喘息のためのトレプロスチニル処置

Publications (2)

Publication Number Publication Date
JP2010518122A JP2010518122A (ja) 2010-05-27
JP2010518122A5 true JP2010518122A5 (US06780888-20040824-C00057.png) 2011-03-10

Family

ID=39357950

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009549268A Withdrawn JP2010518122A (ja) 2007-02-09 2008-02-08 間質性肺疾患および喘息のためのトレプロスチニル処置
JP2013116923A Pending JP2013189459A (ja) 2007-02-09 2013-06-03 間質性肺疾患および喘息のためのトレプロスチニル処置

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013116923A Pending JP2013189459A (ja) 2007-02-09 2013-06-03 間質性肺疾患および喘息のためのトレプロスチニル処置

Country Status (7)

Country Link
US (4) US20080280986A1 (US06780888-20040824-C00057.png)
EP (2) EP2120961A1 (US06780888-20040824-C00057.png)
JP (2) JP2010518122A (US06780888-20040824-C00057.png)
KR (1) KR20090117781A (US06780888-20040824-C00057.png)
CN (2) CN101678033A (US06780888-20040824-C00057.png)
CA (1) CA2678258A1 (US06780888-20040824-C00057.png)
WO (1) WO2008098196A1 (US06780888-20040824-C00057.png)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101780092B (zh) * 2003-05-22 2012-07-04 联合治疗公司 化合物和释放前列环素类似物的方法
ES2340939T3 (es) * 2004-04-12 2010-06-11 United Therapeutics Corporation Utilizacioin del treprostinil para tratar las ulceras de pie diabeticas neuropaticas.
US20070023047A1 (en) * 2005-07-26 2007-02-01 Moshe Zalsman Face mask particularly useful as medical face mask
ES2594368T3 (es) 2005-12-08 2016-12-19 Insmed Incorporated Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares
CN101495122B (zh) 2006-05-15 2011-10-05 联合治疗公司 使用定量吸入器给予曲前列尼
DE102006026786A1 (de) 2006-06-07 2007-12-13 Joachim Kern Dosierinhalator
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
KR101614465B1 (ko) 2007-12-17 2016-04-21 유나이티드 세러퓨틱스 코오포레이션 레모둘린?의 활성 성분인 트레프로스티닐의 개선된 제조 방법
US8350079B2 (en) * 2008-05-08 2013-01-08 United Therapeutics Corporation Treprostinil formulation
KR101544246B1 (ko) * 2009-05-07 2015-08-12 유나이티드 세러퓨틱스 코오포레이션 프로스타시클린 유사체의 고체 제제
US20120184622A1 (en) * 2009-08-07 2012-07-19 Scipharm Sarl Composition for the treatment of cystic fibrosis
ES2611187T3 (es) 2010-03-15 2017-05-05 United Therapeutics Corporation Tratamiento para hipertensión pulmonar
US8481782B2 (en) 2010-06-03 2013-07-09 United Therapeutics Corporation Treprostinil production
WO2012006273A1 (en) * 2010-07-09 2012-01-12 United Therapeutics Corporation Combination therapies with cox-2 inhibitors and treprostinil
WO2012107364A1 (en) * 2011-02-07 2012-08-16 Scipharm Sàrl Novel composition for the treatment of cystic fibrosis
ME02598B (me) * 2011-02-07 2017-06-20 Scipharm Sarl Nova kompozicija za lečenje cistične fibroze
US8461393B2 (en) 2011-03-02 2013-06-11 United Therapeutics Corporation Synthesis of intermediate for treprostinil production
WO2013024051A1 (en) 2011-08-12 2013-02-21 Ascendis Pharma A/S Sustained release composition of prostacyclin
MX349950B (es) 2011-08-12 2017-08-22 Ascendis Pharma As Profarmacos de treprostinil enlazados a un portador.
CN103193627B (zh) 2012-01-10 2016-04-20 上海天伟生物制药有限公司 一种前列腺素类似物的晶型及其制备方法和用途
CN103193626B (zh) 2012-01-10 2016-05-11 上海天伟生物制药有限公司 一种前列腺素类似物的晶型及其制备方法和用途
JP6400479B2 (ja) * 2012-10-29 2018-10-03 株式会社カルディオ 肺疾患特異的治療剤
CN104884047A (zh) 2012-11-29 2015-09-02 英斯梅德股份有限公司 稳定的万古霉素制剂
WO2014110491A1 (en) 2013-01-11 2014-07-17 Theratrophix Llc Prodrugs of treprostinil
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
EP2970091A4 (en) 2013-03-14 2017-02-08 United Therapeutics Corporation Solid forms of treprostinil
WO2014150203A1 (en) 2013-03-15 2014-09-25 United Therapeutics Corporation Salts of treprostinil
JP6263604B2 (ja) 2013-03-25 2018-01-17 ユナイテッド セラピューティクス コーポレイション チオールリンカーを持つ、ペグ化型のプロスタサイクリン化合物の製造方法
PT3060041T (pt) 2013-10-25 2021-03-12 Insmed Inc Compostos de prostaciclina
EP3082428A4 (en) 2013-12-09 2017-08-02 Respira Therapeutics, Inc. Pde5 inhibitor powder formulations and methods relating thereto
CA2949078C (en) * 2014-05-15 2022-09-20 Insmed Incorporated Methods for treating pulmonary non-tuberculous mycobacterial infections
CN106460059B (zh) * 2014-06-03 2021-07-13 诺华股份有限公司 肺动脉高压生物标志物
WO2015192030A1 (en) 2014-06-13 2015-12-17 United Therapeutics Corporation Treprostinil formulations
US9593061B2 (en) 2014-10-20 2017-03-14 United Therapeutics Corporation Synthesis of intermediates for producing prostacyclin derivatives
ES2873873T3 (es) 2014-11-18 2021-11-04 Insmed Inc Métodos de fabricación de treprostinilo y profármacos derivados de treprostinilo
CA2967899C (en) 2014-12-03 2023-09-19 Steadymed Ltd Preservative-free treprostinil formulations and methods and devices for use with same
US9394227B1 (en) 2015-06-17 2016-07-19 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
US9643911B2 (en) 2015-06-17 2017-05-09 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
WO2018058124A1 (en) 2016-09-26 2018-03-29 United Therapeutics Corporation Treprostinil prodrugs
US10799653B2 (en) 2017-01-09 2020-10-13 United Therapeutics Corporation Aerosol delivery device and method for manufacturing and operating the same
CN108379557A (zh) * 2018-01-15 2018-08-10 吉林大学 使用白介素因子-37治疗特发性肺纤维化
EP3773505A4 (en) 2018-03-30 2021-12-22 Insmed Incorporated PROCESS FOR THE CONTINUOUS MANUFACTURING OF LIPOSOMAL MEDICINAL PRODUCTS
WO2020060823A1 (en) 2018-09-18 2020-03-26 Eli Lilly And Company Erbumine salt of treprostinil
BR112021021775A2 (pt) 2019-04-29 2022-01-04 Insmed Inc Composições de pó seco de pró-fármacos de treprostinil e métodos de uso destas
CA3149358A1 (en) 2019-08-23 2021-03-04 United Therapeutics Corporation Treprostinil prodrugs
EP4135707A1 (en) * 2020-04-17 2023-02-22 United Therapeutics Corporation Treprostinil for use in the treatment of intersitial lung disease
CA3180230A1 (en) 2020-06-09 2021-12-16 Hitesh Batra Fumaryl diketopiperidine prodrugs of treprostinil
CA3202061A1 (en) 2020-12-14 2022-06-23 Kenneth Robert Phares Methods of treating disease with treprostinil prodrugs

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4306075A (en) * 1980-03-28 1981-12-15 The Upjohn Company Composition and process
GB8814438D0 (en) * 1988-06-17 1988-07-20 Wellcome Found Compounds for use in medicine
MY106300A (en) * 1988-06-17 1995-04-29 The Wellcome Foundation Ltd Prostaglandin analoques for use in medicine
US6441245B1 (en) * 1997-10-24 2002-08-27 United Therapeutics Corporation Process for stereoselective synthesis of prostacyclin derivatives
DE69822665T2 (de) * 1997-11-14 2005-02-17 United Therapeutics Corp. Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
AU3934000A (en) * 1999-03-18 2000-10-04 United Therapeutics Corporation Inhibitors of endothelin-1 synthesis
US6521212B1 (en) 1999-03-18 2003-02-18 United Therapeutics Corporation Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation
US6756047B2 (en) * 2000-05-12 2004-06-29 The University Of Toledo Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
US7550133B2 (en) * 2002-11-26 2009-06-23 Alexza Pharmaceuticals, Inc. Respiratory drug condensation aerosols and methods of making and using them
CN101780092B (zh) * 2003-05-22 2012-07-04 联合治疗公司 化合物和释放前列环素类似物的方法
CN101495122B (zh) * 2006-05-15 2011-10-05 联合治疗公司 使用定量吸入器给予曲前列尼

Similar Documents

Publication Publication Date Title
JP2010518122A5 (US06780888-20040824-C00057.png)
US9901568B2 (en) Pharmaceutical compositions of 5-hydroxytryptophan and serotonin-enhancing compound
JP4643760B2 (ja) Dpp−iv阻害薬と他の糖尿病治療薬との併用又は組み合せからなる医薬
JP5796959B2 (ja) 関節炎における痛みの治療のためのタペンタドール
JP5208473B2 (ja) アゼラスチンと抗コリン薬を含有する医薬組成物
JP2009525343A5 (US06780888-20040824-C00057.png)
JP2013539790A (ja) メマンチンを含む鎮咳組成物
JP2014521658A5 (US06780888-20040824-C00057.png)
CN107660147B (zh) 用于治疗帕金森病和相关障碍的组合物
JP2007314517A (ja) ロキソプロフェンを含有する鎮咳又は去痰のための医薬組成物
JP2012502047A5 (US06780888-20040824-C00057.png)
WO2011028794A2 (en) Treatment of huntington's disease with cycloserine and an nmda receptor antagonist
US20200360316A1 (en) Combination therapy using acamprosate and d-cycloserine
JP2019533660A5 (US06780888-20040824-C00057.png)
JP2007524699A5 (US06780888-20040824-C00057.png)
TW201811372A (zh) 利用fxr促效劑之方法
JP2015522077A5 (US06780888-20040824-C00057.png)
CN108366981B (zh) 用于治疗与间质性肺病相关的咳嗽的甲磺司特
JP2013501049A5 (US06780888-20040824-C00057.png)
JP5091474B2 (ja) フドステインと抗コリン薬を含有する医薬組成物
JP2008115167A (ja) トラネキサム酸を含有する気道杯細胞過形成抑制剤
JP2017533967A (ja) システアミン組成物を用いるハンチントン病の処置方法
ES2309357T3 (es) Nueva combinacion sinergica que comprende roflumilast y formoterol.
JP2013518061A5 (US06780888-20040824-C00057.png)
WO2007040188A1 (ja) 杯細胞過形成抑制のための医薬組成物